Table 4.
Sarcopenic Obesity | Non-Sarcopenic Obesity | ||
---|---|---|---|
Variables | (n = 31) | (n = 60) | p |
Age (years) | 73.6 ± 3.1 | 74.3 ± 2.9 | 0.36 |
Sex (male/female) | 27/4 | 46/14 | 0.28 |
ASA-PS (1/2) | 7/24 | 14/46 | 1.00 |
Body mass index (kg/m2) | 22.2 ± 2.3 | 20.4 ± 2.8 | <0.01 |
Body mass index >25 kg/m2 | 3 (9.7) | 3 (5.0) | 0.40 |
Visceral fat mass (cm²) | 134.7 ± 36.8 | 75.0 ± 53.3 | <0.01 |
Albumin (g/dL) | 4.10 ± 0.36 | 4.05 ± 0.44 | 0.21 |
CCr | 74.4 ± 12.5 | 74.1 ± 16.4 | 0.92 |
ChE | 307 ± 70 | 281 ± 54 | 0.06 |
T-chol | 188.8 ± 40.1 | 189.9 ± 28.5 | 0.88 |
Hb | 13.8 ± 1.1 | 13.3 ± 1.3 | 0.06 |
SGA (A/B or C) | 26/5 | 27/33 | <0.01 |
Body weight loss rate (%) | 1.7 ± 3.2 | 4.3 ± 6.2 | 0.03 |
%VC | 98.6 ± 16.2 | 101.6 ± 14.6 | 0.38 |
%FEV1.0 | 77.0 ± 6.9 | 76.8 ± 8.3 | 0.90 |
Diabetes mellitus, n (%) | 7 (22.6) | 13 (21.7) | 1.00 |
Cardiovascular disorder, n (%) | 17 (54.8) | 32 (53.3) | 1.00 |
Cerebrovascular disorder, n (%) | 1 (3.2) | 1 (1.7) | 1.00 |
Malignant disease, n (%) | 9 (29.0) | 16 (26.7) | 0.81 |
Chronic disease, n (%) | 3 (9.7) | 7 (11.6) | 1.00 |
Data are expressed as the number of cases or mean number ± standard deviation. ASA-PS, American Society of Anesthesiologists physical status; %VC, percentage vital capacity; %FEV1.0, percentage forced expiratory volume in 1 s; CCr, creatinine clearance; ChE, cholinesterase; T-chol, total cholesterol; Hb, hemoglobin; SGA, subjective global assessment.